These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 926115

  • 1. Synthesis and gastric antisecretory properties of 15-deoxy-16-hydroxyprostaglandin E analogues.
    Collins PW, Dajani EZ, Driskill DR, Bruhn MS, Jung CJ, Pappo R.
    J Med Chem; 1977 Sep; 20(9):1152-9. PubMed ID: 926115
    [Abstract] [Full Text] [Related]

  • 2. Influence of the position of the side chain hydroxy group on the gastric antisecretory and antiulcer actions of E1 prostaglandin analogs.
    Dajani EZ, Driskill DR, Bianchi RG, Collins PW, Pappo R.
    Prostaglandins; 1975 Nov; 10(5):733-45. PubMed ID: 1215536
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and gastric antisecretory properties of 4,5-unsaturated derivatives of 15-deoxy-16-hydroxy-16-methylprostaglandin E1.
    Collins PW, Dajani EZ, Pappo R, Gasiecki AF, Bianchi RG, Woods EM.
    J Med Chem; 1983 Jun; 26(6):786-90. PubMed ID: 6854580
    [Abstract] [Full Text] [Related]

  • 4. Comparative gastric antisecretory and antiulcer effects of prostaglandin E1 and its methyl ester in animals.
    Dajani EZ, Driskill DR, Bianchi RG, Collins PW.
    Prostaglandins; 1975 Aug; 10(2):205-15. PubMed ID: 1178902
    [Abstract] [Full Text] [Related]

  • 5. SC-29333: a potent inhibitor of canin gastric secretion.
    Dajani EZ, Driskill DR, Bianchi RG, Collins PW, Pappo R.
    Am J Dig Dis; 1976 Dec; 21(12):1049-57. PubMed ID: 797257
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of omega-homologues of prostaglandin E1.
    Dajani EZ, Rozek LF, Sanner JH, Miyano M.
    J Med Chem; 1976 Aug; 19(8):1007-10. PubMed ID: 966245
    [Abstract] [Full Text] [Related]

  • 7. Effects of E prostaglandins on canine gastric potential difference.
    Dajani EZ, Callison DA, Bertermann RE.
    Am J Dig Dis; 1978 May; 23(5):436-42. PubMed ID: 677095
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and gastric antisecretory properties of allenic 16-phenoxy-omega-tetranor prostaglandin E analogs.
    Carpio H, Cooper GF, Edwards JA, Fried JH, Garay GL, Guzman A, Mendez JA, Muchowski JM, Roszkowski AP, Van Horn AR.
    Prostaglandins; 1987 Feb; 33(2):169-80. PubMed ID: 3588969
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandins V (1). Synthesis and pharmacology of (+/-)-11-deoxy-10-hydroxyprostaglandin E1 methyl ester.
    Caton MP, Darnbrough G, Hambling DJ, Jordon R, Parker T.
    Prostaglandins; 1979 Oct; 18(4):569-76. PubMed ID: 531225
    [Abstract] [Full Text] [Related]

  • 10. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
    Katz LB, Shriver DA, Tobia AJ, Rosenthale ME.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
    [Abstract] [Full Text] [Related]

  • 11. Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.
    Robert A, Schultz JR, Nezamis JE, Lancaster C.
    Gastroenterology; 1976 Mar; 70(3):359-70. PubMed ID: 174967
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gastric antisecretory effect of 15(R)-15-menthyl PGE2, methyl ester and of 15(S)-15-methyl ester.
    Robert A, Yankee EW.
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):1155-8. PubMed ID: 236577
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and gastrointestinal pharmacology of a 3E,5Z diene analogue of misoprostol.
    Collins PW, Kramer SW, Gasiecki AF, Weier RM, Jones PH, Gullikson GW, Bianchi RG, Bauer RF.
    J Med Chem; 1987 Jan; 30(1):193-7. PubMed ID: 3100798
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP, Garay GL, Baker S, Schuler M, Carter H.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of the effects of prostaglandins and H2-receptor antagonists on gastric acid secretion, mucosal blood flow and ulcer formation.
    Banerjee AK, Christmas AJ, Hall CE.
    Arzneimittelforschung; 1979 Nov; 29(4):634-9. PubMed ID: 39581
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and gastric antisecretory properties of an 8-aza-and a 10-oxa-8,12-secoprostaglandin.
    Zoretic PA, Soja P, Shiah T.
    J Med Chem; 1978 Dec; 21(12):1330-2. PubMed ID: 722746
    [No Abstract] [Full Text] [Related]

  • 19. Azaprostaglandins. Synthesis and antiulcer activity of 11-deoxy-8-azaprostaglandin analogues.
    Baraldi PG, Simoni D, Casolari A, Manfredini S.
    Farmaco Sci; 1983 Jul; 38(7):498-507. PubMed ID: 6617849
    [Abstract] [Full Text] [Related]

  • 20. Effects of 7-oxa-13-prostynoic acid (7-OPyA) and prostaglandin E1 methyl ester on canine gastric secretion.
    Dajani EZ, Driskill DR.
    Prostaglandins; 1977 Oct; 14(4):659-65. PubMed ID: 563608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.